| scholarly article | Q13442814 |
| P2093 | author name string | Juergen A Richt | |
| William C Wilson | |||
| Shawn Babiuk | |||
| Andrea Louise Kroeker | |||
| Bradley S Pickering | |||
| P2860 | cites work | A phytosociological analysis and description of wetland vegetation and ecological factors associated with locations of high mortality for the 2010-11 Rift Valley fever outbreak in South Africa. | Q51144647 |
| Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats. | Q51336493 | ||
| Rift Valley fever vaccines: current and future needs. | Q51784251 | ||
| Modeling tick-borne disease: a metapopulation model. | Q51929575 | ||
| Interspecific network centrality, host range and early-life development are associated with wildlife hosts of Rift Valley fever virus. | Q53682526 | ||
| Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016. | Q54221968 | ||
| Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins. | Q54267574 | ||
| A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting. | Q54942043 | ||
| Susceptibility of White-Tailed Deer to Rift Valley Fever Virus | Q56555971 | ||
| Evidence of Powassan/deer tick virus in adult black-legged ticks (Ixodes scapularis) recovered from hunter-harvested white-tailed deer (Odocoileus virginianus) in Pennsylvania: A public health perspective | Q56560616 | ||
| First occurrence of Rift Valley fever outbreak in Niger, 2016 | Q58572518 | ||
| The Ecological Significance and Implications of Transovarial Transmission among the Vector-Borne Bunyaviruses: A Review | Q59349730 | ||
| Molecular aspects of Rift Valley fever virus and the emergence of reassortants | Q59351098 | ||
| Productive Propagation of Rift Valley Fever Phlebovirus Vaccine Strain MP-12 in Rousettus aegyptiacus Fruit Bats | Q60925687 | ||
| RVFV Infection in Goats by Different Routes of Inoculation | Q60959433 | ||
| The influence of raw milk exposures on Rift Valley fever virus transmission | Q63246310 | ||
| Rift Valley Fever Virus and Yellow Fever Virus in Urine: A Potential Source of Infection | Q64127190 | ||
| Rift valley fever | Q71188972 | ||
| Suburban white-tailed deer seropositive for Toxoplasma gondii from Chicago, Illinois | Q92100201 | ||
| Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas | Q92802082 | ||
| Increased Susceptibility of Cattle to Intranasal RVFV Infection | Q94926559 | ||
| Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement | Q24655645 | ||
| A sero-epidemiological study of arboviral fevers in Djibouti, Horn of Africa | Q24701790 | ||
| Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus Infection | Q24706511 | ||
| Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa? | Q26314582 | ||
| Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus | Q26315437 | ||
| Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe | Q26795706 | ||
| The 2007 Rift Valley fever outbreak in Sudan | Q27026883 | ||
| Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity | Q27305179 | ||
| Widespread Rift Valley Fever Emergence in Senegal in 2013–2014 | Q27468927 | ||
| Differential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived Alphaviruses | Q27478027 | ||
| Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry | Q27478367 | ||
| Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep | Q27481669 | ||
| Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya | Q27482900 | ||
| Studies on Rift Valley fever in some African murids (Rodentia: Muridae) | Q27482975 | ||
| An epidemic of Rift Valley fever in Egypt. 2. Isolation of the virus from animals | Q27486135 | ||
| Rift Valley Fever Outbreak, Mauritania, 1998: Seroepidemiologic, Virologic, Entomologic, and Zoologic Investigations | Q27487840 | ||
| Isolation and Genetic Characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia | Q27489553 | ||
| Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission | Q28742390 | ||
| The global emergence/resurgence of arboviral diseases as public health problems | Q29616270 | ||
| Mosquito Biting Modulates Skin Response to Virus Infection | Q29994498 | ||
| Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. | Q31149260 | ||
| Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley Fever virus | Q33497390 | ||
| Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt | Q33651877 | ||
| Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system | Q33755025 | ||
| Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003. | Q33884060 | ||
| Host alternation is necessary to maintain the genome stability of rift valley fever virus | Q33918307 | ||
| An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007 | Q34034053 | ||
| Rift Valley Fever Virus Epidemic in Kenya, 2006/2007: The Entomologic Investigations | Q34034059 | ||
| Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep | Q40358602 | ||
| Rift Valley fever virus: an unrecognized emerging threat? | Q40360325 | ||
| Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers | Q40397884 | ||
| Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA. | Q40400233 | ||
| Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States | Q40426903 | ||
| Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. | Q40453546 | ||
| Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. | Q40473787 | ||
| The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization | Q40499509 | ||
| Could bats act as reservoir hosts for Rift Valley fever virus? | Q40630335 | ||
| Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids | Q40645618 | ||
| Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle | Q40645625 | ||
| Distribution of viral antigen in tissues of new-born lambs infected with Rift Valley fever virus. | Q40660109 | ||
| Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
| Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation | Q40774379 | ||
| Viral determinants of virulence for Rift Valley fever (RVF) in rats | Q40782624 | ||
| Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA. | Q40785843 | ||
| Vector potential of selected North American mosquito species for Rift Valley fever virus | Q40788381 | ||
| Messenger RNA of the M segment RNA of Rift Valley fever virus | Q40808123 | ||
| Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. II. Ultrastructural findings | Q40844064 | ||
| The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses | Q40845919 | ||
| Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep | Q40858817 | ||
| Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine | Q40866726 | ||
| The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs | Q40879284 | ||
| Host and Potential Vector Susceptibility to an Emerging Orbivirus in the United States: Epizootic Hemorrhagic Disease Virus Serotype 6. | Q40956224 | ||
| The pathogenesis of Rift Valley fever in lambs | Q40989584 | ||
| The case for a 'one health' approach to combating vector-borne diseases | Q41460881 | ||
| Rift Valley Fever: Does Wildlife Play a Role? | Q41922817 | ||
| Tempering the risk: Rift Valley fever and bioterrorism | Q44936397 | ||
| Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model | Q47562012 | ||
| Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination | Q50329180 | ||
| One Health approach to Rift Valley fever vaccine development | Q38200401 | ||
| Rift Valley Fever: An Emerging Mosquito-Borne Disease | Q38776944 | ||
| Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States. | Q38964465 | ||
| NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
| The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies | Q39240187 | ||
| Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. | Q39251803 | ||
| Wicking assay for the rapid detection of Rift Valley fever viral antigens in mosquitoes (Diptera: Culicidae). | Q39526935 | ||
| The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
| Diagnostic approaches for Rift Valley fever | Q39597325 | ||
| The potential role of Rattus rattus in enzootic cycle of Rift Valley Fever in Egypt. 1-Detection of RVF antibodies in R. rattus blood samples by both enzyme linked immuno sorbent assay (ELISA) and immuno-diffusion technique (ID). | Q39618675 | ||
| Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008. | Q39725145 | ||
| NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription | Q39960501 | ||
| Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. | Q40048134 | ||
| Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy | Q40059072 | ||
| Aedes Aegypti saliva enhances chikungunya virus replication in human skin fibroblasts via inhibition of the type I interferon signaling pathway | Q40060321 | ||
| Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment | Q40108424 | ||
| Development of a sheep challenge model for Rift Valley fever. | Q40123495 | ||
| Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination | Q40170227 | ||
| Comparative efficacy of two next-generation Rift Valley fever vaccines | Q40199478 | ||
| Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs | Q40203534 | ||
| Development of a Rift Valley fever virus viremia challenge model in sheep and goats | Q40214312 | ||
| Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus? | Q40225260 | ||
| Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments | Q40241448 | ||
| Detection and identification of Rift Valley fever virus in mosquito vectors by quantitative real-time PCR. | Q40279271 | ||
| A network-based meta-population approach to model Rift Valley fever epidemics | Q40287896 | ||
| Efficacy of three candidate Rift Valley fever vaccines in sheep. | Q40292321 | ||
| Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories | Q40302542 | ||
| DC-SIGN as a receptor for phleboviruses | Q40318139 | ||
| Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves | Q40322035 | ||
| Potential for stable flies and house flies (Diptera: Muscidae) to transmit Rift Valley fever virus | Q40335291 | ||
| Potential for North American Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus | Q40346522 | ||
| Comparison of Enzyme-Linked Immunosorbent Assay–Based Techniques for the Detection of Antibody to Rift Valley Fever Virus in Thermochemically Inactivated Sheep Sera | Q40348202 | ||
| Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates. | Q40348206 | ||
| The Historical and Recent Impact of Rift Valley Fever in Africa | Q34034064 | ||
| Prediction, Assessment of the Rift Valley Fever Activity in East and Southern Africa 2006–2008 and Possible Vector Control Strategies | Q34034069 | ||
| Epidemiological Assessment of the Rift Valley Fever Outbreak in Kenya and Tanzania in 2006 and 2007 | Q34034081 | ||
| Rift Valley Fever Outbreak in Livestock in Kenya, 2006–2007 | Q34034103 | ||
| Detection of rift valley Fever virus interepidemic activity in some hotspot areas of kenya by sentinel animal surveillance, 2009-2012. | Q34101068 | ||
| An unexpected recurrent transmission of Rift Valley fever virus in cattle in a temperate and mountainous area of Madagascar | Q34113798 | ||
| Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep | Q34221766 | ||
| Innate immune response to Rift Valley fever virus in goats | Q34251382 | ||
| Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection | Q34260234 | ||
| The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts | Q34440401 | ||
| A systematic review of Rift Valley Fever epidemiology 1931-2014. | Q34487937 | ||
| A hierarchical network approach for modeling Rift Valley fever epidemics with applications in North America | Q34717000 | ||
| Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya | Q34805801 | ||
| A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. | Q35027744 | ||
| Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes | Q35097798 | ||
| Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. | Q35107614 | ||
| Relationship of climate, geography, and geology to the incidence of Rift Valley fever in Kenya during the 2006-2007 outbreak | Q35716641 | ||
| Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines | Q35797105 | ||
| Unexpected Rift Valley fever outbreak, northern Mauritania | Q35847618 | ||
| Molecular epidemiology of Rift Valley fever virus | Q35849036 | ||
| Potential effects of Rift Valley fever in the United States | Q36053652 | ||
| NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
| A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection | Q36481559 | ||
| Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals | Q36484009 | ||
| Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever | Q36548980 | ||
| Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. | Q36632198 | ||
| Rift Valley fever in Namibia, 2010. | Q37343711 | ||
| The risk of Rift Valley fever virus introduction and establishment in the United States and European Union | Q37433782 | ||
| Rift Valley Fever Outbreak in Livestock, Mozambique, 2014. | Q37535789 | ||
| Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets | Q37547173 | ||
| Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host | Q37547686 | ||
| Rift Valley fever--a threat for Europe? | Q37733822 | ||
| Animal models of Rift Valley fever virus infection | Q37956499 | ||
| Breaking the chain: Rift Valley fever virus control via livestock vaccination | Q37998608 | ||
| The role of wild mammals in the maintenance of Rift Valley fever virus | Q38001682 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Rift Valley fever | Q326638 |
| P304 | page(s) | 238 | |
| P577 | publication date | 2020-05-27 | |
| P1433 | published in | Frontiers in Veterinary Science | Q27726928 |
| P1476 | title | Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing | |
| P478 | volume | 7 |
Search more.